INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 273 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,953,000 | -17.9% | 1,465,125 | -11.5% | 0.07% | -10.3% |
| Q2 2023 | $68,124,000 | -30.7% | 1,656,306 | -3.3% | 0.08% | -33.3% |
| Q1 2023 | $98,298,000 | +2.7% | 1,712,219 | +0.3% | 0.12% | +3.5% |
| Q4 2022 | $95,709,000 | +28.3% | 1,706,963 | -3.0% | 0.11% | +24.2% |
| Q3 2022 | $74,584,000 | -0.9% | 1,759,996 | +26.3% | 0.09% | +7.1% |
| Q2 2022 | $75,288,000 | -15.3% | 1,393,451 | +0.7% | 0.08% | +25.0% |
| Q1 2022 | $88,937,000 | -3.9% | 1,384,021 | +0.2% | 0.07% | -11.7% |
| Q4 2021 | $92,564,000 | -3.9% | 1,381,757 | -1.8% | 0.08% | -6.1% |
| Q3 2021 | $96,370,000 | +0.7% | 1,407,275 | +0.4% | 0.08% | +3.8% |
| Q2 2021 | $95,665,000 | +11.5% | 1,401,893 | +12.9% | 0.08% | -34.7% |
| Q1 2021 | $85,767,000 | +3.8% | 1,241,376 | -2.5% | 0.12% | 0.0% |
| Q4 2020 | $82,666,000 | +56.8% | 1,273,356 | +14.0% | 0.12% | +36.0% |
| Q3 2020 | $52,722,000 | +75.7% | 1,116,518 | +74.8% | 0.09% | +71.2% |
| Q2 2020 | $30,010,000 | +1175.4% | 638,628 | +1112.0% | 0.05% | +940.0% |
| Q1 2020 | $2,353,000 | -20.6% | 52,692 | +3.6% | 0.01% | +25.0% |
| Q4 2019 | $2,963,000 | +10.2% | 50,845 | +13.6% | 0.00% | -20.0% |
| Q3 2019 | $2,689,000 | +19.1% | 44,770 | +9.7% | 0.01% | +25.0% |
| Q1 2018 | $2,258,000 | -19.2% | 40,805 | -20.5% | 0.00% | -20.0% |
| Q2 2017 | $2,796,000 | +29.4% | 51,300 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $2,161,000 | -11.0% | 51,300 | +74.5% | 0.00% | -20.0% |
| Q3 2016 | $2,427,000 | -48.3% | 29,400 | -50.0% | 0.01% | 0.0% |
| Q2 2016 | $4,692,000 | +97.9% | 58,800 | +67.0% | 0.01% | 0.0% |
| Q1 2016 | $2,371,000 | -0.6% | 35,200 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $2,386,000 | +13.8% | 35,200 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $2,096,000 | -11.6% | 35,200 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $2,371,000 | +9.3% | 35,200 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $2,170,000 | +13.7% | 35,200 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,909,000 | +9.3% | 35,200 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,747,000 | – | 35,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |